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Aconitum and its products have been used in Asia for centuries to treat various ailments,
including arthritis, gout, cancer, and inflammation. In general, their preparations and
dispensing have been restricted to qualified folk medicine healers due to their low safety
index and reported toxicity. In the past few decades, official guidelines have been intro-
duced in Asian pharmacopeias to control Aconitum herbal products. However, these
guidelines were based on primitive analytical techniques for the determination of the
whole Aconitum alkaloids and were unable to distinguish between toxic and nontoxic
components. Recent advances in analytical techniques, especially high performance liquid
chromatography (HPLC) and electrophoresis coupled with highly sensitive detectors,
allowed rapid and accurate determination of Aconitum secondary metabolites. Reports
focusing on liquid chromatography/mass spectrometry analysis of Aconitum and its herbal
products are discussed in the current review. This review can be used by the healthf Natural Products, Collage of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708,
, College of Pharmacy, China Medical University, Taichung 404, Taiwan.
(F.-R. Chang), yachwu@mail.cmu.edu.tw (Y.-C. Wu).
s work.
inistration, Taiwan. Published by Elsevier Taiwan LLC. This is an open access article under the CC
/licenses/by-nc-nd/4.0/).
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creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Aconitum (or monkshood) is a herb native to China and certain
parts of Europe [1,2]. It has been used for centuries to treat pain
due to arthritis, gout, cancer, inflammation, migraine, and
sciatica. Despite such important therapeutic activities, it is
highly toxic and ingestion of the raw material can lead to
arrhythmia, heart failure, and even death. Even topical appli-
cations can be dangerous because its toxic alkaloids can be
absorbed through the skin [3]. Toxicity of aconite is related to the
C19-norditerpenoid ester alkaloids such as aconitine (AC),
deoxyaconitine (DA),mesaconitine (MA),hypaconitine (HA), and
yunaconitine (YA) [4]. These alkaloids significantly activate so-
dium channels and cause widespread membrane excitation in
cardiac, neural, and muscular tissues [5e8]. Additionally,
muscarinic activation may cause hypotension and bradyar-
rhythmia. Symptoms of Aconitum sp. poisoning include numb-
ness followed by paralysis of the upper and lower extremities.
Patients with aconite poisoning, due to the consumption of
herbal broth containing a large amount of Fuzi, usually suffer
from cardiovascular symptoms including chest pain, palpita-
tion, bradycardia, sinus tachycardia, ventricular ectopics, ven-
tricular tachycardia, and ventricular fibrillation [9,10]. Themain
causes of death from aconite include ventricular arrhythmias
andasystole [11]. There isnospecificantidote for aconitepoising
butonly supportive treatment to restorenormalheart functions.
The supportive treatment of aconite poisoning includes the
use of amiodarone and flecainide as antiarrhythmic agents.
Intragastric lavage or oral administration of charcoal can
decrease alkaloid absorption.A fatal dose canbe as little as 5mL
of aconite tincture, 2mgofpure aconite, or 1 g of the root [12,13].
For decreasing the toxicity, aconite must be processed prior to
use. To date, more than 70 traditional and modern methods
have been applied to decrease the toxicity of aconite roots
[13,14].According to theChinesePharmacopeia, only twoassays
are accepted for the quantitative analysis of alkaloids in Aconi-
tum sp. Based on these two assays, the maximum allowance of
alkaloid content, calculated taking AC into consideration, is
0.15% and 0.20%, respectively. Any herbal product with a lower
concentration of the toxic alkaloids can be used in China, but
such regulation is not acceptable elsewhere. Microscopic ex-
amination of the processed aconite roots (P-ARs) reveals the
presence of gelatinized starch masses, which do not appear in
the unprocessed aconite root (unP-AR) samples [15].
The plant is rich in diterpene and norditerpene alkaloids as
the major active constituents. These compounds exhibit inter-
esting activity toward voltage-gated Na channel either as ago-
nists (e.g.ACandMA)orasantagonists (e.g., lappaconitineand6-
benzoylheteratisine) [16e18]. Activities toward certain neuronal
receptors were also noted such as norditerpene alkaloids (e.g.,
methyllycaconitine). These alkaloids exhibited selective antag-
onistic activity on the neuronal nicotinic acetylcholine receptorinananomolar rangeofconcentration, rendering it asapotential
drug lead in Alzheimer diseases [19e21].2. Historical glimpse
The name Aconitum comes from the Greek word akonitos,
meaning “without struggle” or “without dust,” or from the
Greek city Acona, where a naturalist in the 3rd century once
identified the plant [22]. Other historical sources suggest that
the name came from the hill of Aconitus. It is a hill in Greek
mythology where Hercules fought with Cerberus, the three-
headed dog that guards the entrance to Hades. Saliva from
this creature dripped onto the plant, rendering them
extremely poisonous. It is also claimed that the cup-shaped
flower made the poisonous cup that Medea prepared for
Theseus. The plant played an important role in Roman his-
tory, as it is assumed that Nero ascended to the throne after
poisoning Claudius by tickling his throatwith a feather dipped
in monkshood. The emperor Trajan (98e117 AD) banned
growing of this plant in all Roman domestic gardens [23]. One
of the most remarkable pieces describing the role played by
this plant in ancient Roman society was described by the
writer Ovid. He referred to aconite as the “step-mother's poi-
son.” In his work Metamorphoses, he described a certain
period of Roman history by the following lines:
“Guest was not safe from host, nor father-in-law from son-in-
law; even among brothers it was rare to find affection. The
husband longed for the death of his wife, she of her husband; and
murderous step-mothers brewed deadly poisons, and sons
inquired into their fathers' years before the time.”
Shakespearehighlighted thepotencyof thisherb inhisnovel
Romeo and Juliet, in which he stated that Romeo committed
suicide using this poison [22]. In addition, in Macbeth, the
witches' brew calling for “tooth of wolf” refers to monkshood.
Certain species are also known as wolfsbane because arrows
dipped in the poison kill wolves. Until 1930, it was used in the
USAandCanadaas a painkiller, diuretic, anddiaphoretic. Itwas
used externally in the form of ointments to treat rheumatism,
neuralgia, and lumbago and as a tincture to lower pulse rate,
relieve fever, and treat cardiac failure. Reported cases of toxicity
led to the ban of its use in conventional medication.3. Liquid chromatography/mass
spectrometry techniques for analyzing Aconitum-
containing samples
Modern analytical techniques have been employed in the last
2 decades to evaluate herbal medicines sold in Asian markets
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[24e26]. Aconitum and its products are strictly monitored due
to their extreme toxic components, especially diester-
diterpenoid alkaloids (DDAsdAC, MA, and HA). Initially,
alkaloidal titration methods were used to monitor these al-
kaloids. However, compared with the high-performance
liquid chromatography (HPLC) method, alkaloidal titration
method estimates not only toxic DDAs, but also monoester-
diterpenoid alkaloids (MDAs), unesterified alkaloids, and
lipo-alkaloids (LPAs) [27], which are less toxic than DDAs and
may have potential effect, especially for inflammatory disor-
ders such as arthritis [28]. Therefore, HPLC became the pop-
ular method to detect DDAs and MDAs [MDAs such as
benzoylaconine (BAC), benzoylmesaconine (BMA), and ben-
zoylhypaconine (BHA)] in recent days.
The degradation of DDAs into MDAs were noted in meth-
anol and ethanol [29,30], especially for AC. Thus, using
ethanol ormethanol as the extraction solvent ormobile phase
in HPLC may lead to inaccurate results. Hydrolysis of DDAs
intoMDAs is observed especially with a long decoction time (>
120 minutes) [28]. This degradation phenomenon was detec-
ted upon using water as the decoction solvent, as well as cow
urine and cow milk (Tables 1 and 2) [31]. Furthermore, the
stability of DDAs was found to be highly pH dependent and
they were stable only in the range of 2.0e7.0. The relative
concentrations of DDAs, especially AC and MA, decreases
significantly at pH >10 [29]. The evidence showed that storing
DDAs in an ambient temperature or at 4C may cause degra-
dation, and samples are suggested to be kept at 20C to
decrease the degradation rate [32].
To reduce decomposition of DDAs, chloroform and
dichloromethane were found to be the most appropriate
extraction solvents [29,33]. Although 1% hydrochloride as the
extraction solvent could improve the extraction yield, degra-
dation of DDAs occurred [34]. To shorten the extraction time,
an ultrasonic bath [35] or a microwave-assisted extraction
procedure [36] was applied. The choice of the mobile phase
plays an important role in the resolution of alkaloidal peaks
on HPLC. Acetonitrileeaqueous 0.1% formic acid [37], aceto-
nitrileeacetic acid solution [38], or acetonitrileeammonium
bicarbonate buffer at pH 10 ± 0.5 [39,40] resulted in excellent
peak resolution in several studies.
Recent studies introduced new protocols, which did not
require sample preparation, and the herbal products were
analyzed in their crude forms. DART-MS (direct analysis in
real time mass spectrometry) plus multivariate data analysis
method was utilized as a solvent-free method to analyze
samples directly in their native condition, without the need of
tedious sample manipulation and preparation [41]. Moreover,
minimum amounts of samples were analyzed with high ac-
curacy with the introduction of new methods such as ultra-
high pressure liquid chromatography with linear trap quad-
rupole and Orbitrap mass spectrometry system (UHPLC-LTQ-
Orbitrap-MSn) [42].
Aconite is usually combined with other Chinese herbs by
practitioners of traditional Chinese medicine (TCM). In order
to detect the recovery of toxic alkaloids in these formulas,
many liquid chromatography/mass spectrometry (LC/MS)-
related techniques were used, such as ultraperformance
liquid chromatographyeelectrospray ionization/massspectrometry (UPLCeESI/MS) [43], Ultraperformance liquid
chromatographyephotodiode array detector (UPLCePDA) [44],
UPLC/MS [45], UPLCequadrupole time-of-flight mass spec-
trometry (Q-TOFeMS) [46], ultrafast liquid chromatography-
eion trap/time-of-flightmass spectrometry (UFLC/MS-IT-TOF)
[47], and UPLCeESIeQ-TOFeMS [48]. In recent years, various
aconite-relatedmedications were introduced into the Chinese
market. In order to speed up the quality control process, rapid
resolution liquid chromatography coupled with tandemmass
spectrometry (RRLCeMS/MS) was applied to analyze the toxic
alkaloids in these products such as Shen-Fu formula. This
method provides excellent limit of quantification (LOQ)
(7e50 pg/mL) as well as limit of detection (LOD) (2.3e17 pg/mL)
[49], which are much more sensitive than LC/MS.
There are many Aconitum sp. in the world (> 75 species);
some of themare used in folkmedicine, especially in Asia. The
processing methods differ from country to country and from
use to use. Determination of fingerprints for raw herbs and
medicinal formulas is essential for the establishment of
appropriate quality control procedures. Certain studies
introduced similarity evaluation, hierarchical cluster analysis,
or principal component analysis (PCA) to evaluate the simi-
larity and variation of aconite samples [37,50]. Partial least
squares-discriminant analysis (PLS-DA) and orthogonal pro-
jection to latent structure analysis were extremely useful in
the classification of metabolic phenotypes and in the identi-
fication of different metabolites [51].
This review covers recent attempts to establish analytical
protocols developed to analyze products containing alkaloids
of raw herb or P-ARs using HPLC/MS-related techniques. Sig-
nificant accomplishments were reported, showing in detail
the optimum procedures to evaluate alkaloidal contents of
aconite samples. Most of the important findingswere reported
in the past 15 years starting from the year 2000, and this re-
view summarizes important studies using different HPLC/MS-
related laboratory equipment in a chronological order.
Xie et al [39] developed an efficient protocol using HPLC for
the separation of six aconite alkaloids, including AC, MA, HA,
BAC, BMA, and BHA, in aconite roots and related 12 pro-
prietary Chinese medicines (Tables 1 and 2). They found that
ethyl acetate was the optimum solvent for extracting alka-
loids from the basified solution. They also evaluated the effect
of pH on the separation of alkaloids, and found that all peaks
were separated at pH above 9.95 and the optimum pH value
for separation was 10.0 ± 0.2. The effect of using different
concentrations (5mM, 10mM, or 20mM) of ammonium car-
bonate, the mobile phase buffer, was studied. It was found
that the optimum concentration was 10mM for excellent peak
separation and background noise reduction. Alkaloidal peaks
were identified by comparing their retention time and UV
spectra with the reported data. This method was applied for
the identification of 12 aconite-root-containing Chinese
medicines, and two P-AR and two unP-AR samples. As ex-
pected, P-ARs showed lower levels of the toxic alkaloid AC.
However, concentrations of the other toxic alkaloids, HA and
MA, were significantly higher than that of AC in the P-AR
samples, suggesting that the use of AC concentration as the
only marker for toxicity reduction after processing is not
enough for general safety guidelines.
Table 1 e Representative sample preparation procedures for aconite roots and their products in recent publications.
Analytes Samples Extraction procedures Analysis Refs
Monoester-diterpene alkaloids
BMA P-AR & its proprietary products containing processed aconite
roots
Extract P-AR with 50% EtOH (3, 60 min each time) via
sonication & alkaloids from unP-AR via general method.a
HPLC-PDA [30]
Diester-diterpene alkaloids
AC, MA, & HA P-AR & unP-AR Extract P-AR& unP-ARwith 75% EtOH (3, 30min each time) via
sonication.
HPLC-PDA [52]
AC, MA, & HA Aconite roots & decoction pieces containing processed aconite
roots
Extract with methanolewater (1:1, v/v) via sonication for
60 min.
HPLC-PDA & HPLCeESIeMS [35]
AC, MA, & HA Aconite roots Extract using the general extraction procedures.a HPLC-PDA [40]
AC, MA, & HA Shen-Fu decoction (Radix ginseng & Fuzi at a ratio of 3:2)
containing processed aconite roots
Extract with water under reflux (1:10 v/v, 3, 60 min each time),
& dissolve the corresponding residue in water.
RRLCeESIeMS/MS [65]
AC, MA, & HA Unprocessed aconite roots Extract P-AR& unP-AR with chloroform (1:10 v/v, for 30min) via
sonication & dissolve the obtained residue in methanol.
UPLCeQ-TOFeMS [31]
Simultaneous analysis for both monoester & diester diterpene alkaloids
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
P-AR, unP-AR & proprietary Chinese medicines (pills, tablets, &
capsules) containing processed aconite roots
Extract by alkaloidal extraction procedures.a HPLC-PDA [39]
MDAs: BAC, BMA, & BHA Raw material & P-AR Extract by alkaloidal extraction procedures.a
Dissolve the corresponding residue was dissolved in ACNeTEA
(75:25, v/v).
HPLC-PDA & HPLCeESIeMS/MS [38]
DDAs: AC, MA, & HA
MDAs: BAC, BMA, & BHA P-AR & its proprietary products (Xiaohuoluo pills) Add ammonia TS (40% NH3$H2O) to each sample & extract with
diethyl ether in an ultrasonic bath for 30 min, & dissolve the
corresponding residue with methanol. To each sample of pills,
add ammonia TS (40% NH3$H2O) & extract with isopropanol
eethyl acetate (1:1, v/v) in an ultrasonic bath for 30 min, &
dissolve the corresponding residue in acetonitrile.
UPLCeESIeMS [37]
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, HA, & YA
P-AR, unP-AR, & its patent Chinese medicine products (pills)
containing processed aconite roots
Extract with 50% methanol (containing 2.5% formic acid) by
microwave for 1 min at a power level of 420 W.
UPLCeESIeMS/MS [36]
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
Decoction & maceration of Fuzi Xiexin Tang containing P-AR Extract with water under reflux (1:10 & 1:8 v/v, 2, for 1 h or
1.5 h)& dissolve the corresponding residue inwater. Maceration
of FXT: reflux the weighted sample of Radix Aconiti Lateralis
Preparata with water (1:10 & 1:8 v/v, 2, for 1 h or 1.5 h) &
combine the corresponding decoction with another prepared
maceration of Sanhuang Xiexin Tang to obtain MFXT.
UPLCeESIeMS [43]
Simultaneous analysis for the nonester, monoester, & diester diterpene alkaloids
Nonester type: higenamine
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
Fuzi decoction (Heishunpian & Baifupian) Extract with water under reflux (1:10, v/v, 3, for 60 min each
time) & dissolve the corresponding residue in water.
RRLCeESIeMS/MS [49]
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Nonester type
(aminoalcohol-
diterpenoid alkaloids):
beiwutinine; mesaconine;
karakoline;
isotalatizidine; aconine;
8-methoxymesaconine;
hypaconine; fuziline; 3-
deoxyaconine; neoline; 8-
methoxyhypaconine;
talatizamine; &
chasmanine
21 batches of Fuzi from different regions; all the samples were
processed from the lateral roots of A. carmichaelii
Extract by alkaloidal extraction proceduresa & solid-phase
extraction, & dissolve the corresponding residue in methanol
e0.1% formic acid (80:20, v/v).
HPLCeESIeMS/MS [66]
Nonester type: songorine;
fuziline; neoline;
talatisamine; guanfubase
H
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
Shen-Fu injection prepared from red ginseng & processed
aconite root
Prepare each sample in acetonitrileewater (1:1, v/v). UPLCeQ-TOFeMS [46]
AC ¼ aconitine; BAC ¼ benzoylaconine; BHA ¼ benzoylhypaconine; BMA ¼ benzoylmesaconine; DDA ¼ diester-diterpenoid alkaloid; ESI ¼ electrospray ionization; HA ¼ hypaconitine; HPLC ¼ high-
performance liquid chromatography; MA ¼ mesaconitine; MDA ¼ monoester-diterpenoid alkaloid; MFXT ¼ maceration of Fuzi Xiexin Tang; MS ¼ mass spectrometry; MS/MS ¼ tandem mass
spectrometry; MSXT ¼maceration of Fuzi Xiexin Tang; P-AR ¼ processed aconite root; Q-TOF ¼ quadrupole time of flight; RRLC ¼ rapid resolution liquid chromatography; TOF ¼ time of flight; unP-
AR ¼ unprocessed aconite root; UPLC ¼ ultra-performance liquid chromatography; YA ¼ yunaconitine; PDA ¼ Photodiode Array Detector; ACN ¼ acetonitrile; TEA ¼ triethylamine; EtOH ¼ ethanol.
a Alkaloid extraction procedure: each sample was dissolved/extracted in HCl/ammonia solution by sonication, and further extracted with ethyl acetate/ethyl ether to remove nonalkaloid compo-
nents. The acidic/basic aqueous solution was basified/acidified with ammonia/HCl solution to adjust the pH value, and extracted with chloroform/ethyl ether to obtain the alkaloid components.
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Table 2 e Analytical methods of aconite roots and their proprietary products.
Method Analytes Samples Details Refs
Analysis methods for monoester diterpene alkaloids
HPLC-PDA BMA P-AR; proprietary products
containing processed
aconite roots
Alltima RP-C18 (250  4.6 mm, 5 mm) was used with the Alltima RP-C18 guard column (7.5  4.6 mm) at
room temperature. Elution of the alkaloids was carried out using a gradient system of acetonitrile &
buffer solution at a flow rate of 1.0 mL/min, detected at 240 nm, validated with linearity, LOD, precision,
repeatability, & recovery.
[30]
Analysis methods for diester diterpene alkaloids
HPLC-PDA AC, MA, & HA P-AR & unP-AR Waters Xterra RP18 column (250  4.6 mm, 5 mm) was used with the Xterra RP18 guard column
(20  3.9 mm) at room temperature. Elution of the alkaloids was carried out using a gradient system of
acetonitrile & 10 mM ammonium bicarbonate buffer solution at a flow rate of 1.0 mL/min, detected at
240 nm, validated with linearity, LOD, precision, repeatability, & recovery.
[52]
HPLC-PDA & HPLCeESI/MS AC, MA, & HA Aconite roots & decoction
pieces containing processed
aconite roots
Waters Xterra RP18 column (250  4.6 mm, 5 mm) was used & column temperature maintained at 25  C.
Mobile phase was carried out using a gradient system of 2.5 mM ammonium bicarbonate in water at pH
10& acetonitrile at a flow rate of 1.0mL/min, detected at 240 nm& positive ionmode for ESI/MS, validated
with linearity, LOD, LOQ, precision, repeatability, & recovery.
[35]
HPLC-PDA AC, MA, & HA Aconite roots Phenomenex Luna C18 column (250 4.6mm, 5 mm)was used& column temperaturemaintained at room
temperature. Mobile phase was carried out using a gradient system of acetonitrile & ammonium
bicarbonate buffer solution at a flow rate of 1.0mL/min, detected at 231 nm, validated with linearity, LOD,
LOQ, precision, repeatability, & recovery.
[40]
RRLCeESI/MS/MS AC, MA, & HA Shen-Fu decoction (Radix
Ginseng & Fuzi at a ratio of
3:2) containing processed
aconite roots
Agilent ZORBAXC18 SB column (100 mm  2.1 mm, 1.8 mm) was used & column temperature maintained
at 40 C. The gradient mobile phases consisted of water containing 0.05% formic acid & acetonitrile at a
flow rate of 0.35 mL/min. The positive ion mode for ESI/MS/MS (totally 10 major components identified, 3
DDAs from Fuzi) was validated & quantitatively analyzed.
[65]
UPLCeQ-TOFeMS AC, MA, & HA unP-AR Separation of components in the samples was performed at 20  C, using a Waters UPLC C18 analytical
column (100mm 2.1mm, 1.7 mm) attachedwith a C18 precolumn (2.1mm 5mm, 1.7 mm). The gradient
mobile phase consisted of a mixture of water & acetonitrile, both containing 0.1% formic acid at a flow
rate of 0.4 mL/min. The three analytes of unprocessed aconite roots & the corresponding detoxification
process samples were validated & qualified using the UHPLCeQ-TOFeMS in positive ion mode.
[31]
Simultaneous analysis methods for both monoester & diester diterpene alkaloids
HPLC-PDA MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
P-AR, unP-AR, & proprietary
Chinese medicines (pills,
tablets, & capsules)
containing processed
aconite roots
Alltima RP-C18 (250  4.6 mm, 5 mm) was used as the stationary phase accompanied by Alltima RP-C18
guard column (7.5  4.6 mm) at room temperature. Elution of the six alkaloids was carried out using a
gradient system of acetonitrile & buffer solution at a flow rate of 1.0 mL/min, detected at 240 nm,
validated with linearity, LOD, precision, repeatability, & recovery.
[39]
HPLC-PDA & HPLCeESI/MS/
MS
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
Raw material & P-AR Microsorb C18 column (250  4.6 mm, 5 mm) was used with an Econosphere C18 guard column, & column
temperature maintained at 45  C. Mobile phase was carried out using a gradient system of ACN, TEA
buffer & THF at a flow rate of 1.0 mL/min, detected at 238 nm, validated with linearity, LOD, LOQ,
precision, repeatability,& recovery,& detected& quantified with ESI/MS/MS spectra in positive ionmode.
[38]
UPLCeESIeMS MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
P-AR & its proprietary
products (Xiaohuoluo pills)
Agilent ZORBAXC18 SB column (100 mm  2.1 mm, 1.8 mm) was used & column temperature maintained
at 35 C. Mobile phase was carried out using a gradient system of 0.1% aqueous formic acid & acetonitrile
(65:35, v/v) at a flow rate of 0.3 mL/min. Quantification analysis was achieved on ESI/MS in positive ion
mode & SIR mode, validated, & quantitatively analyzed.
[37]
UPLCeESIeMS/MS MDAs: BAC, BMA, & BHA
DDAs: AC, MA, HA, & YA
P-AR, unP-AR & its patent
Chinese medicine products
(pills) containing processed
aconite roots
Waters Acquity UPLC BEHC18 column (100 mm  2.1 mm, 1.7 mm) was used for chromatographic
separation & column temperature maintained at 40 C. The gradient mobile phase consisted of a mixture
of 0.1% formic acid aqueous solution & methanol-1,4-dioxane (80:20, containing 0.1% formic acid) at a
flow rate of 0.6 mL/min. Quantification analysis was achieved using ESI/MS/MS in positive ion mode &
MRM mode, validated, & quantitatively analyzed.
[36]
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UPLCeESIeMS MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
Decoction & maceration of
Fuzi Xiexin Tang containing
processed aconite roots
Waters Acquity UPLC BEHC18 column (50 mm  2.1 mm, 1.7 mm) was used for the chromatographic
separation & column temperature maintained at 45 C. The gradient mobile phase consisted of 0.1%
formic acid aqueous solution & acetonitrile at a flow rate of 0.3 mL/min. Quantification analysis was
achieved on ESI/MS in positive ion mode & SIR mode, validated, & quantitatively analyzed.
[43]
Simultaneous analysis for nonester, monoester, & diester diterpene alkaloids
RRLCeESIeMS/MS Nonester type: higenamine
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
e
Fuzi decoction
(Heishunpian & Baifupian)
The separation was carried out on an Agilent ZORBAXC18 SB column (100  2.1 mm, 1.8 mm) & column
temperature maintained at 40 C. The gradient mobile phase consisted of 0.1% formic acid aqueous
solution & acetonitrile at a flow rate of 0.35 mL/min. Quantification analysis was achieved using ESI/MS/
MS in positive ion mode & MRM mode, validated, & quantitatively analyzed.
[49]
HPLCeESIeMS/MS Nonester type
(aminoalcohol-diterpenoid
alkaloids): beiwutinine;
mesaconine; karakoline;
isotalatizidine; aconine; 8-
methoxymesaconine;
hypaconine; fuziline; 3-
deoxyaconine; neoline; 8-
methoxyhypaconine;
talatizamine;& chasmanine
21 batches of Fuzi from
different regions; all the
samples were processed
from the lateral roots of A.
carmichaelii
Chromatographic separations the thirteen alkaloids were performed on a Hypersil ODS2 column
(4.6 mm  150 mm, 5 mm), which was conjuncted with a SecurityGuard cartridge (Phenomenex) at
ambient temperature. The isocratic mobile phase was composed of methanol-0.1% formic acid (80:20, v/
v) at a flow rate of 1.0 mL/min. Quantification analysis was achieved using ESI/MS/MS in positive ion
mode & MRM mode, validated & quantitatively analyzed.
[66]
UPLCeQ-TOFeMS & HPLC
eESI/MS
Nonester type: songorine;
fuziline; neoline;
talatisamine; guanfubase H
MDAs: BAC, BMA, & BHA
DDAs: AC, MA, & HA
e
Shen-Fu injection prepared
from red ginseng & P-AR
Chromatographic separation for 11 alkaloids was performed on an Agilent Zorbax SB-C18 column
(4.6 mm  250 mm, 5 mm) at 30C. The gradient mobile phase consisted of 10mM ammonium formate
ewater & 0.1% formic acid acetonitrile at a flow rate of 1.0 mL/min. Quantification analysis was achieved
on ESI/MS in positive ion mode & selected ion monitoring mode, validated, & quantitatively analyzed.
[46]
AC ¼ aconitine; BAC ¼ benzoylaconine; BHA ¼ benzoylhypaconine; BMA ¼ benzoylmesaconine; DDA ¼ diester-diterpenoid alkaloid; ESI ¼ electrospray ionization; HA ¼ hypaconitine; HPLC ¼ high-
performance liquid chromatography; LOD ¼ limit of detection; LOQ ¼ limit of quantification; MA ¼ mesaconitine; MDA ¼ monoester-diterpenoid alkaloid; MRM ¼ multiple reaction monitoring;
MS ¼mass spectrometry; MS/MS ¼ tandemmass spectrometry; P-AR ¼ processed aconite root; Q-TOF ¼ quadrupole time of flight; RRLC ¼ rapid resolution liquid chromatography; SIR ¼ selected ion
recording; TOF ¼ time of flight; UHPLC ¼ ultra-high-performance liquid chromatography; unP-AR ¼ unprocessed aconite root; UPLC ¼ ultra-performance liquid chromatography; YA ¼ yunaconitine.
jo
u
r
n
a
l
o
f
f
o
o
d
a
n
d
d
r
u
g
a
n
a
l
y
s
is
2
4
(2
0
1
6
)
2
9
e
4
5
3
5
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 2 9e4 536Quantitation of AC, MA, and HA in different P-AR and unP-
AR samples was achieved using LC (Tables 1 and 2) [52]. The
effect of the extraction solvent was studied through the use of
different concentrations of ethanol (50%, 75%, or 90%). Based
on the results, 75% ethanol showed the highest level of HA
recovery. In addition, the effects of extraction duration (30
minutes or 60 minutes) and extraction cycles (3 times or 5
times) were studied, which showed no advantages on the
alkaloid recovery yields with longer extraction time or more
extraction cycles. In the optimization steps of the HPLC pro-
tocol, the effect of pH was evaluated, showing that all peaks
were efficiently separated at pH above 9.5. The LOD for all
alkaloids was 15 ng. Marked differences in alkaloidal contents
of the P-AR samples showed lower levels of the three alkaloids
compared to those of the unP-AR samples. However, a varia-
tion among the P-AR samples was also observed, whichmight
be attributed to the uses of different aconite species,
geographical sources, or processing methods. It is noteworthy
to mention that despite the fact that AC concentration was
lower than the limit established by the Chinese pharmaco-
peia, concentrations of other alkaloids were higher than that
of AC in some samples, suggesting that the detection of
multiple alkaloidal markers is needed to clarify the toxicity
level of aconite preparations.
The variation in alkaloidal contents among four different
species of Aconitum (Aconitum carmichaelii, Aconitum pendulum,
Aconitum hemsleyanum, and Aconitum transsectum) was studied
using HPLC [53]. Different solvents were tested as the mobile
phase to separate BMA, MA, AC, HA, and DA from the samples
of the four Aconitum sp. Meth-
anolewaterechloroformetriethylamine/0.1% trifluoroacetic
acidetetrahydrofuran and methanolewatereacetonitrile/
acetonitrile and ammonium hydrogen carbonate buffer were
evaluated, and the use of the latter solvent system resulted in
the best separation. Separation was optimized at 35C using a
gradient elution. The LOD for the developed method was 
30 ng/mL, with a recovery percentage of > 94.65% for all five
alkaloids. The results revealed a significant variation in the
alkaloidal contents of the four species, highlighting the
importance of using the correct species with known alkaloidal
contents in the herbal preparations intended for consumer
use.
Tang et al [54] developed a protocol for the determination
of AC, HA, and MA in a variety of matrixes, including raw
materials, single-ingredient powder extracts, multi-
ingredient powder extracts, pills, and capsules, using HPLC
coupled with UV detection, and the results were confirmed
using tandem mass spectrometry. The authors used liquid-
eliquid extraction followed by solid-phase extraction to
remove interferences prior to LC separation. The extraction
solvent had a significant effect on the alkaloidal yields, with
diethyl ether solubilizing more neutral alkaloids compared
to the dichloromethane. The use of amixture of diethyl ether
and dichloromethane resulted in a cleaner background but a
lower yield. It was also found that the longer the extraction
time under alkaline conditions, the more the alkaloids
become susceptible to hydrolysis. The effect of the mobile
phase additives on the efficiency of separation of alkaloids
was studied, which showed that the optimum separation
was achieved using 20mM triethylamine (TEA) and 5%methanol. The results of LCeUV and LC/MS/MS were in close
agreement.
The stability of DDAs was studied using HPLC/ESI/MSn [29].
The information on stability is crucial for the estimation of the
herbal products' biological activity as well as their toxicity.
The stability of DDAs in different solvents was investigated,
the results showing that these alkaloids are stable in
dichloromethane but not inmethanol. It was found that when
ether was used as the extracting solvent, AC concentration
declined to 51.8%, but concentrations of the other alkaloids
MA and HA did not change more than 10%. This finding sug-
gested that the extraction process should be carried out as
soon as possible, to avoid decomposition of AC. Different
substituents at the nitrogen atom of DDAs led to different
rates of decomposition. Moreover, the effect of pH was eval-
uated, which showed that the three alkaloids AC, MA, and HA
were stable in the pH range of 2.0e7.0. If the pH values of the
buffer solutions were in the range of 7e10, the relative con-
centrations of AC and MA were significantly decreased. If the
pH was above 10, the three alkaloids decomposed. The effect
of storage on AC concentration was studied, which showed
that storing aconite at pH 8 and 25C for 6 months resulted in
50% reduction of AC concentration.
An HPLC method was developed for estimating the
quantity of BMA as the main constituent of aconite alkaloids
in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots;
Tables 1 and 2) [30]. BMA was reported to possess potent
pharmacological activities, such as analgesic and anti-
inflammatory activities. Several extracting solvents were
evaluated for their efficiency in extracting BMA, revealing
that the optimum solvent was 50% ethanol. In the optimi-
zation process for the development of the HPLC analytic
methods, it was found that the use of acetonitrile and
phosphoric acid (0.1%) with triethylamine as the mobile
phase improved peak symmetry. Lowering the pH below 2.6
or raising the pH above 4.9 resulted in a longer elution time,
so the elution was carried out at pH 3.0. The LOD for BMA was
found to be 8 ng with an injection volume of 20 mL. The study
also concluded that significant variations in BMA concen-
trations were observed among different batches of the P-ARs
and among different proprietary products, indicating the
importance of strict quality control for any herbal product
containing aconite.
The use of oxidative-damaged endothelial (ECV304) cells
along with LCeMS was applied for the detection of bioactive
alkaloids of Aconitum szechenyianum [55]. The developed sys-
tem depends on the interaction of the alkaloidal extract with
endothelial cells. The extract was subjected to oxidative stress
using H2O2, followed by the aggregation of cell membrane
proteins through changing the pH to 4.0, to release the special
binding components from cell receptors. Separation and
analysis of the alkaloidal content were achieved using HPLC,
and characterization of these components was performed by
LCeMS. In the obtained fingerprint of A. szechenyianum, five
peaks were detected, and by studying the fragmentation
pattern of these compounds, two compounds were identi-
fieddMA and AC.
A matrix-assisted laser desorption ionization mass spec-
trometry (MALDI-MS) method was developed for the qualita-
tive profiling of the P-ARs of the Chinese herbal medicine A.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 2 9e4 5 37carmichaelii, Fuzi [32]. The use of the developed protocol
eliminated the need for sample preparation, and the method
was applied directly to powdered roots. Results of the MALDI-
MS experiments were compared with those of LCeMS, and
both results were in agreement with each other. The authors
used LCeMS for characterization of Fuzi components result-
ing in the detection of 60 peaks, which were divided into three
groups. One group with retention times below 8 minutes and
molecular weight (MW) of 400e500, the second group with
retention times between 8minutes and 12minutes andMWof
500e800, and the third group with retention times of more
than 12 minutes and MW above 800 were detected. The effect
of storing the samples at different temperatures was evalu-
ated by measuring the degradation rate in a standard solution
of aconite upon storing at 20C, 4C, and room temperature.
At 20C, the standard solution showed the lowest degree of
degradation, suggesting the importance of storing the aconite
samples at a low temperature. This study concluded that the
tested batches of Fuzi showed significant variation in the
concentrations of DDAs, as demonstrated by MALDI-MS and
LCeMS.
An HPLC coupled with a diode array detector (HPLC-DAD
protocol was developed for the identification and quantifica-
tion of the three major aconite alkaloids, including AC, MA,
and HA, in the roots of A. carmichaelii [56]. Contents of LPAs in
the roots of A. carmichaelii were evaluated using liquid chro-
matography atmospheric-pressure chemical ionization mass
spectrometry (LC-APCI-MSn), indicating the presence of 26
LPAs. These compounds are interesting from different per-
spectives, because they possess several pharmacological ac-
tivities and many AC-type alkaloids are converted to LPAs in
the intestine. The authors showed that LPAs can be detected
in the P-AR and unP-AR samples. By contrast, the three major
AC-type alkaloids, AC, MA, and HA, could not be detected in
the P-AR samples. The major alkaloid in the unP-AR sample
was MA. In this study, the anti-inflammatory activity of the P-
AR and unP-AR sampleswas evaluated using a COX-inhibitory
assay. Both samples showed moderate COX-2 inhibitory ac-
tivity, with the P-AR samples showing a slightly more potent
effect.
A detailed study on the fragmentation pattern of aconite
alkaloids was conducted by Yue et al [57]. They identified 111
compounds out of 117 from A. carmichaelii using HPLC/
ESIeMS/MSn and Fourier transform ion cyclotron resonance/
ESIeMS in the positive ion mode. Among the identified alka-
loids, 11 MDAs, 10 DDAs, and 81 LPAs, as well as novel alka-
loids, including one MDA, two DDAs, and 48 LPAs, were
detected in A. carmichaelii. Moreover, one DDA, seven LPAs,
and two alkaloids with small MWs that possess C19-
norditerpenoid skeleton were reported in A. carmichaelii for
the first time.
HPLC was also applied for the analysis of an Ayurvedic
herbal product, Mahamrutyunjaya Rasa, which is composed
of Aconitum ferox, Solanum indicum, Piper nigrum, and Piper
longum in a ratio of 1:1:1:1 [33]. The marker compounds for
these components are AC, solanine, and piperine. The effect
of the extracting solvent on alkaloidal recovery was studied
through comparing the alkaloidal yields with the use of
chloroform, ethyl acetate, or diethyl ether. The optimum
solvent for extraction was chloroform. In the optimizationprocess for developing the HPLC method, pH showed a sig-
nificant effect on the separation of the three marker com-
pounds as well as their separation from other interfering
chemicals. The optimum separation was achieved at pH
7.5e8.0. The composition of the mobile phase was studied by
evaluating the separation of marker compounds using
acetonitrile, KH2PO4 buffer, and methanol at different con-
centrations, including 65:15:15, 60:25:15, and 55:35:15 (v/v),
showing the best separation at 60:25:15. The LOD and LOQ for
AC were 0.210 mg/mL and 0.693 mg/mL, respectively. The re-
sults indicated that the concentration of AC varied across the
tested samples and the Relative Standard Deviation (%RSD)
values were > 10%. These findings highlighted the impor-
tance of strict regulation during the preparation of Ayurvedic
herbal products containing aconite.
An HPLC-DAD method assisted by similarity hierarchical
clustering analysis was applied for the identification of four
species of Aconitum roots [58]. The root fingerprints were
established and compared. The method was validated,
showing its potential in differentiating the roots of Aconitum
kusnezoffii (AKR) from other species. The effect of the extrac-
tion methods on the yields of MA, AC, and HA was evaluated.
The samples were extracted using an ultrasonic bath with
different volumes of diethyl ether at different extraction
times. It was found that the optimum results were obtained
using 10 mL of ether for 30 minutes. These results were
compared with the results of the normal extraction pro-
cedures using a percolator. Soaking the roots for 24 hours
yielded results similar to the ultrasonic extraction for 30 mi-
nutes, and thus the ultrasonic extraction was selected as the
optimum extraction method. An isocratic mobile phase
composed of acetonitrilee0.25% glacial acetic acid (60:40, v/v),
with pH ¼ 10.5 adjusted using ammonia, was selected for
elution. Ten samples of AKR grown at different cultivation or
wildness regions, in various cultivating environments, or in
different harvesting years were analyzed and their finger-
prints were compared. Ten peaks were selected as common
peaks in all samples. Careful analysis of these peaks revealed
that the relative peak areas varied dramatically, but the rela-
tive retention times were consistent for all the 10 samples.
When the chromatographic profile of Aconitum karacolicum
was compared with the AKR profile, five common peaks were
detected. When the chromatographic profiles of morphologi-
cally similar species, Aconitum austroyunnanense and Aconitum
contortum, were comparedwith the chromatographic profile of
AKR, significant differences were observed, as illustrated by
the absence of certain characteristic peaks in the profile of A.
austroyunnanense and A. contortum. These findings were
confirmed using hierarchical clustering analysis, which
showed that the samples could be divided into three clusters.
One cluster included all AKR samples, another cluster con-
tained all A. karacolicum samples, and the last cluster con-
tained A. austroyunnanense and A. contortum samples,
suggesting the reliability of this method in differentiating AKR
samples from other closely related aconite species.
Lu et al [35] investigated the effect of different processing
methods on the content of toxic alkaloids in A. carmichaelii
(Fuzi; Tables 1 and 2). They processed the samples according
to the methods reported by the Chinese herbal medicine
practitioners. The content of AC, MA, and HA in the tested
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and LCeMS. The efficiency of different solvents [methanol,
methanolewater (1:1, v/v), and water] in extracting the
target alkaloids was evaluated, and methanolewater (1:1, v/v)
was found to be the optimum solvent. Effects of the extraction
time, volume, and repetitions of the alkaloidal yields were
evaluated. To extract 0.5 g of the powder, ultrasonication for
60 minutes using 5 mL of methanolewater (1:1, v/v) was
required to achieve 98% recovery of the three alkaloids. The
optimum mobile phase was composed of acetonitrile and
ammonium bicarbonateeammonium hydroxide, with pH
adjusted at 10. Different wavelengths, 220 nm, 232 nm, and
240 nm, were evaluated for the detection of the three peaks,
and 240 nm was found to be the optimum wavelength. The
detection limits for AC, MA, and HA were found to be 0.9 mg/
kg, 0.6 mg/kg, and 1.3 mg/kg, respectively. The quantitation
limit was estimated to be 3.5 mg/kg for AC, 2.2 mg/kg for MA,
and 4.8 mg/kg for HA. The results were in agreement with
previous reports, suggesting that processing of aconite roots
significantly reduces their toxicity as the sum of the toxic al-
kaloids was 3.91e34.80% of the original value in raw Fuzi.
An HPLC/ESIeMSn method was developed for the quanti-
fication of LPAs in Radix Aconiti, Radix Aconiti Kusnezoffii,
and Radix Aconiti Lateralis Preparata [59]. Different solvents
were evaluated, and methanol was found to be the optimum
mobile phase for the highest resolution of the LPA peaks. The
developed method was applied for the analysis of the three
herbs, resulting in the identification of 32 alkaloids based on
their fragmentation pathway. The average recovery percent-
ages of the alkaloids were 91.1e105.9%.
The concentrations of AC, MA, and HA in A. carmichaelii, A.
pendulum, AKR, Aconitum taipeicum, and A. szechenyianumwere
determined using an efficient HPLC method (Tables 1 and 2)
[40]. The extraction process was optimized by L16 (45)
orthogonal test and univariant methods. These methods
indicated that the optimum extraction procedures of the al-
kaloids can be achieved by refluxing the sample three times in
six volumes of acidic alcoholic solution for 1 hour. The
average recovery rates forMA, AC, andHA ranged from 99.49%
to 101.9%, from 101.2% to 103.1%, and from 96.62% to 98.43%,
respectively. The mobile phase was optimized after testing
the effect of using acetonitrilee0.2% acetic acid (adjusted to
pH 6.25 with triethylamine), acetonitrileephosphate buffer
(pH ¼ 8.67), acetonitrileeammonium bicarbonate buffer
(pH¼ 8.50e9.00), ormethanoleammonium bicarbonate buffer
(pH¼ 8.00e10.00) on peak resolution. The best separation was
obtained using acetonitrileeammonium bicarbonate buffer at
pH 9.5.
Aconitum-type alkaloids were analyzed in one famous
Chinese herbal formula, Yin Chen Si Ni Tang, which is used for
the treatment of liver disorders and jaundice [48]. This for-
mula contains Artemisiae scopariae (Yinchenhao), Radix Aco-
niti Lateralis Preparata (prepared Fuzi), Rhizoma Zingiberis
(Ganjiang), and Radix et Rhizoma Glycyrrhizae Preparata Cum
Melle (prepared Gancao). Several components in this formula,
including flavonoids and coumarins, hindered the analysis of
Aconitum-type alkaloids. The developed UPLCeESIeQ-
TOFeMS method along with the postacquisition data pro-
cessing software, Metabolynx XS, succeeded in the identifi-
cation of Aconitum-type alkaloids in Yin Chen Si Ni Tang.Using the developed method, 62 ions were assigned to Aconi-
tum-type alkaloids and identified tentatively by comparing the
information on their accurate mass and fragments with that
of the authentic standards or by MS analysis and retrieving
the reference literatures.
Functionalized analysis was applied for the detection of
Aconitum-type alkaloids from A. carmichaelii using vascular
endothelial growth factor receptor cell membrane chroma-
tography with LCeMS [60]. This method depends on the
detection of the inhibitory effect of the target compounds on
vascular endothelial growth factor receptor and thus pre-
dicting their potential as future cytotoxic compounds. Using
this protocol, factions separated by the vascular endothelial
growth factor receptor cell membrane chromatography col-
umn (the 1st dimension) were transferred and adsorbed on an
enrichment column, which were sent to the LCeMS system
(the 2nd dimension) for separation and preliminary identifi-
cation. The results indicated that the active compounds of A.
carmichaelii were MA, AC, and HA.
The efficiency of alkaloidal titration, the method utilized
for the quality control of herbal products containing aconite
recommended by the Chinese Pharmacopeia, was compared
to an HPLC method developed for the identification of MA,
AC, and HA in commercial samples of P-ARs [27]. The results
showed that no toxic alkaloids were detected in any of the
commercial samples, indicating that the processing method
was efficient in removing the toxic alkaloids from the sam-
ples. The validity of the method was demonstrated through
subjecting the samples to in vivo tests showing no signs of
toxicity. When the results of the HPLC method were
compared to the alkaloidal titration method, a significant
discrepancy in the results was observed. The alkaloidal
titration method indicated that the samples still contained
0.2% alkaloids. The main drawback of the alkaloidal titration
method is the lack of specificity to the toxic alkaloids,
because it estimates not only the toxic DDAs, but also the
MDAs, unesterified, and LPAs. These results suggested the
importance of using different methodologies for estimating
the toxicity of herbal products containing Aconitum-type
alkaloids.
An HPLCmethodwas developed for the analysis of AC, MA,
and HA in the Chinese herbs Caowu (CW) and Chuanwu
(CHW) (Tables 1 and 2) [38]. Separation of these alkaloids was
highly affected by the concentration of triethylamine phos-
phate in buffer solution, and the best separation was achieved
using 25mM triethylamine phosphate. The average recovery
rates of AC, MA, and HA were found to be 91%, 89%, and 87%,
respectively. Concentrations of the three alkaloids were less
in the processed CHW compared to those in other processed
samples. The effects of boiling raw herbs in water for different
periods of times were also studied, which showed that AC and
MA disappeared after boiling in water for 150 minutes. How-
ever, HA was found to survive the heating process, suggesting
its importance as a marker for herbal products containing
aconite. The validity of the HPLC method was confirmed by
comparing its results with the results of an automated
analytical system (HPLC) and ESI/MS/MS. The results were
comparable, suggesting the future potential application of the
developed method in investigating the quality of herbal
products containing aconite.
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analysis of alkaloids in the unprocessed Radix Aconiti and
Radix Aconiti Preparata [61]. The effects of the extraction
method (soaking or ultrasonic bath), extracting solvent (50%
ethyl acetateeisopropanol, 80% ethyl acetateeisopropanol,
ethanol, methanol and acetone), solvent volume (50, 100 and
200 mL), extraction time (30, 60 or 120 min) and extraction
times (once, twice or three times) were evaluated. The opti-
mum result was obtained using the following conditions: 5.0 g
of the ground powder was soaked for 10 minutes in ammonia
water (5.0 mL) at pH 10, and then the mixture was extracted
with a 100 mL mixture of ethyl acetateeisopropanol (1:1) by
ultrasonication (30 minutes). The optimal mobile phase was
acetonitrile and 0.1% v/v glacial acetic acid. The developed
method was applied for the analysis of the P-AR and unP-AR
samples, and the obtained peaks were identified as AC alka-
loids. The detected peaks were divided into three groups: (1)
alkaloids with MW 400e500, which were named as nonester
alkaloids; (2) alkaloids with MW 500e800, which were
assigned as DDAs and MDAs; and (3) alkaloids with MW > 800,
which were identified as LPAs.
A rapidmethodwas developed for the analysis of YA in the
P-AR and unP-AR samples as well as in TCM preparations
containing aconite herbs (Tables 1 and 2) [36]. YA is often
ignored in the quality control measures of herbal preparations
containing aconite despite its reported toxicity. To detect this
alkaloid, a UHPLCeMS/MSmethod was developed, which was
able to detect YA as well as AC, MA, HA, BAC, BMA, and BHA.
Microwave-assisted extraction was utilized to extract the
target alkaloids. The solvent for microwave-assisted extrac-
tion was 50% methanol (containing 2.5% formic acid) and the
irradiation power was 420W for 1minute. Thirty-one samples
were analyzed, and the contents of the seven alkaloids were
determined. Alarmingly, the content of YA varied significantly
in some of the evaluated samples, from 0.015 mg/g to
10.41 mg/g. A concentration of 10.41 mg/g is toxic and should
be controlled, suggesting the importance of detecting the
concentration of YA in aconite-containing herbal products.
A UHPLC-LTQ-Orbitrap-MSnmethod was developed for the
analysis of DDAs in A. carmichaelii [42]. Using the developed
method, the authors were able to detect or characterize 42
DDAs. The fragmentation patterns of the major diagnostic
alkaloids, including AC, MA, and HA, were investigated. Using
the developed method, 23 new compounds were suggested,
including 16 esterified DDAs with short fatty acid esters along
with four N-dealkyl-type DDAs. The authors showed the ad-
vantages of using UHPLC with its small-particle-size station-
ary phase (1.7mm) in comparisonwith the conventional HPLC
(5.0 mm), resulting in improved resolution and shorter anal-
ysis time.
The safety of Xiaohuoluo pill, a TCM, which is used in
mainland China to treat wind cold damp impediment, limb
pains, and numbness, has been the subject of recent in-
vestigations (Tables 1 and 2) [37]. This TCM is composed of
Radix Aconiti Preparata and Radix Aconiti Kusnezoffii Pre-
parata as the main herbs, accounting for 42% of the entire
prescription. It is sold in herbal drugmarkets and produced by
several suppliers without extensive quality control measures.
An efficient UPLCeESIeMS method was developed for the
rapid analysis of the Xiaohuoluo pill, and the results ofanalyzing different samples were evaluated using chemo-
metric analysis of PCA and orthogonal projection to latent
structural discriminant analysis. In the process of developing
the analytical methods, it was found that the positive ion
mode response was much higher than the response in the
negative ionmode for MA, AC, HA, BMA, BHA, and BAC, which
might be attributed to the ionization of the nitrogen atom in
the alkaloids. The optimum mobile phase was found to be
acetonitrileewater containing 0.1% formic acid (35:65, v/v) for
the best resolution and peak shapes. Using the developed
method, the lower LOQs for MA, AC, HA, BMA, BAC, and BHA
were found to be 1.41 ng/mL, 1.20 ng/mL, 1.92 ng/mL, 4.28 ng/
mL, 1.99 ng/mL, and 2.02 ng/mL, respectively. Recovery per-
centages of these alkaloids ranged from 99.7% to 101.7%. The
developed method was applied for the analysis of different
samples. The results indicated that in the Xiaohuoluo pill,
concentrations of the DDAs (MA, AC, and HA) were obviously
less than those of the MDAs (BMA, BAC, and BHA), indicating
the potent effect of herbal processing in changing the alka-
loidal concentrations. The quantitative determination of al-
kaloids in the Xiaohuoluo pill indicated that MA, AC, and HA
concentrations were below the required level, as suggested by
the Chinese Pharmacopeia. These results suggested that the
studied Xiaohuoluo pill is safe for use, if the indicated dosage
and regimen are followed.
A ultra-performance liquid chromatography coupled with
quadrupole time-of-flight high-definition mass spectrometry
(UPLCeQ-TOF-HDMSn)methodwas developed for the analysis
of the crude lateral roots of A. carmichaelii and three P-AR
products, Yanfuzi, Heishunpian (HSP), and Baifupian (BFP),
which are used by TCM practitioners [62]. Themethod utilized
PCA for establishing the differences between the metabolic
profiles of P-AR and unP-AR samples. The authorswere able to
select 19 metabolites as biomarkers, and they detected the
changes in their concentrations as a result of processing. The
results indicated that processing was effective in decreasing
the concentrations of DDAs. Concentrations of AC, MA, HA,
DA, 10-OH-mesaconitine, in Heishunpian and BFP, were
significantly decreased, while those of these alkaloids
increased in Yanfuzi. This finding suggested that despite the
widely accepted assumption that processing is highly effec-
tive in decreasing the toxicity of herbal products containing
aconite, P-AR products should be carefully analyzed.
An HPLCeESIeMSn method was developed for the identi-
fication of alkaloids in the crude and processed A. carmichaelii
[34]. The alkaloids were extracted from the herb using 1% (v/v)
hydrochloric acid, which extracted most of the alkaloids. It
was found that the addition of ammonia to the mobile phase
depressed tailing of the peaks. BAC and BMA could not be
separated if the ammonia concentration was less than 1%.
Application of the developed method to the analysis of A.
carmichaelii led to the identification of 48 AC-type alkaloids by
studying their MSn spectral data. The crude and processed
chromatograms were compared, which indicated that the
contents of MDAs increased after processing, while the con-
centrations of DDAs decreased.
An LCeMS method was developed for the analysis of al-
kaloids in the processed Fuzi decoctions, Baifupian and
Heishunpian (Tables 1 and 2) [49]. During the process of
method development, the effects of the mobile phase on the
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showed that the best peak shape and resolution can be ach-
ieved using a mixture of acetonitrile and an aqueous 0.1%
formic acid solution. Seven alkaloids were detected, including
higenamine, BHA, BMA, BAC, AC, HA, and MA. The LOQs were
7.80 pg/mL for higenamine, 25.00 pg/mL for BHA and BAC,
10.00 pg/mL for AC and MA, and 50.00 pg/mL for BMA and HA.
The LODs ranged from 2.30 pg/mL to 17.00 pg/mL for the tar-
geting alkaloids. Application of the method for differentiating
between Baifupian and Heishunpian decoctions revealed sig-
nificant variation in the alkaloidal contents among these de-
coctions. As demonstrated in many other studies,
concentrations of certain toxic DDAs decreased significantly
with processing; however, this trend was not universal for all
DDAs. Contents of AC and MAwere much lower than those of
BAC and BMA in Heishunpian and Baifupian decoctions. By
contrast, the concentration of HA in Heishunpian and Baifu-
pian decoctions was higher than that in BHA. The analysis
also indicated that the concentrations of BHA, HA, and BAC in
Heishunpian decoction were higher than those in Baifupian
decoction. However, contents of MA and BMA in Heishunpian
decoction were lower compared with those of Baifupian
decoction. These findings supported the notion that the vari-
ation in the processing protocols can lead to a significant
variation in alkaloidal concentrations.
A detailed investigation on the effect of different process-
ing techniques on the alkaloidal content of Radix Aconiti was
achieved using UPLCeESI/MSn [50]. After establishing the
fingerprints of the P-AR and unP-AR samples, similarity
evaluation, hierarchical cluster analysis, and PCA were per-
formed to evaluate the similarity and variation of the samples.
The authors processed the samples according to the Chinese
Pharmacopeia, and they labeled the P-AR samples as the
qualified Radix Aconiti and the unP-AR samples as the un-
qualified Radix Aconiti. The total ion chromatograms of the P-
AR and unP-AR samples showed significant variations, espe-
cially in the region of the DDAs. It was revealed that the
content of MDAs was higher in the P-AR samples than that in
the unP-AR samples. The results also indicated that BMA was
the abundant compound in the P-AR samples. Due to the
concentration variations between DDAs andMDAs along with
sensitivity limitation of the spectroscopic techniques, the
authors suggested that quantitative determination of MDAs
can be achieved using UPLCeUV, and DDAs can be detected
using UPLCeESI/MS. Contents of LPAs decreased significantly
after the first hours of processing and then remained con-
stant. The decline in the concentration was attributed to the
hydrolysis of LPAs under the processing conditions and the
afterward stability to the reaction of MDAs, DDAs, and fatty
acids forming LPAs. PCA was used for the analysis of themain
alkaloidal markers affecting the quality of samples. Finger-
prints of the nine analyzed samples were obtained and the
characteristic peaks, 39 common peaks from total ion chro-
matograms of UPLCeESI/MSn and 34 common peaks from
UPLCeUV chromatograms, were identified.
A microcalorimetric assay along with a UPLC method were
applied for the analysis of five different species of aconite,
including Radix Aconiti, Radix Aconiti Singularis, Radix Aco-
niti Kusnezoffii, Radix Aconiti Lateralis Preparata, and Radix
Aconiti Brachypodi [63]. Using the developed UPLC method,fingerprints of the five Aconitum plants were established. Bio-
logical effect of the alkaloids in the tested Aconitum sp. on
Escherichia coli metabolism was studied using a microcalori-
metric assay. Themetabolic process of E. coliwas studied, and
it was found that the process can be divided into different
phases: the first exponential phase (AeB), the lag phase (BeC),
the second exponential phase (CeD), and the decline phase
(DeE). The effect of using different concentrations of Aconitum
sp. was studied, which showed significant changes in the
metabolic curvewith various concentrations of plant samples.
A comparison of the fingerprints of the aconite samples led to
the identification of 15 common peaks. Among these peaks,
those corresponding to AC, HA, and MA were identified. The
correlation between these peaks and the changes in E. coli
metabolism was established, which showed that MA and HA
had a negative effect on metabolism, while AC was found to
promote bacterial metabolism.
A UPLCeQ-TOF-HDMS method was developed for the
analysis of alkaloidal contents in the roots of AKR (CW), the
mother root of A. carmichaelii (CHW), and the daughter or
lateral roots ofA. carmichaelii [“Shengfuzi” in Chinese] [51]. The
results indicated that the optimum mobile phase was 0.1%
formic acid in water and 0.1% formic acid in acetonitrile. After
analyzing the samples using the developed method, certain
statistical tools were applied, including PCA, PLS-DA, and
orthogonal projection to latent structure analysis. These tools
helped in the classification of the metabolic phenotypes and
identification of the differentiating metabolites. The PCA re-
sults are shown as score plots indicating the scatter of the
samples. If the score plots are clustered together, this in-
dicates similar metabolomic compositions, whereas they are
considered compositionally different if the score plots are
dispersed. PLS-DA predicts a list of metabolites through
measuring the distance from different groups. The S-plot is
utilized to identifymetabolites according to the orders of their
contributions to the separation of clustering. Using these
statistical tools, 22 metabolites between Shengfuzi and CHW
and 13 metabolites between CHW and CW were identified as
biomarkers. Interestingly, concentrations of MA and AC were
higher in CW. This phenomenon was attributed to the fact
that CW is grown in cold weather, which may induce the
production of toxic alkaloids. Moreover, it was found that
songorine, carmichaeline, and isotalatizidine were absent in
CW, despite their presence in Shengfuzi and CHW.
The effect of adding Cinnamomum cassia to the alkaloidal
content of Sini Tang, which is formed of Zingiber officinale,
Glycyrrhiza uralensis, and A. carmichaelii, was studied using
HPLC-DAD [64]. Certain complexes were formed, which were
analyzed using proton nuclear magnetic resonance (1H-NMR)
and UV/Vis spectroscopy. To clearly study the effect of
complexation on toxic alkaloids of A. carmichaelii, eight
batches of the P-AR and one batch of the unP-ARA. carmichaelii
roots, as well as one batch of G. uralensis roots, Z. officinale
rhizome, and C. cassia bark were tested. A. carmichaelii roots
were processed by repeatedly soaking them in salt water and
boiling until the sliced roots turned black before drying in an
oven. The processed samples of A. carmichaelii were analyzed
using HPLC. Based on the obtained chromatograms, AC and
MA contents were below the LOD in all batches. Only HA was
detected and thus was selected as the marker compound.
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that HA could be detected only if MeOH was used as the
extracting solvent; however, other organic solvents were un-
able to extract HA. HPLC analysis of the unprocessed batch of
A. carmichaelii extracted with MeOH indicated the presence of
HA (269.34 þ 0.58 mg/g). The use of 1% HCl yielded 251.12 mg/g
HA, MeOH:H2O (1:1) furnished 199.48 mg/g HA, and 71.32 mg/g
HA was obtained using H2O. However, analysis of the pre-
pared A. carmichaelii decoction did not show any traces of HA.
The effect of combining other herbs with A. carmichaelii, such
as G. uralensis, Z. officinale, and C. cassia, on HA content was
studied. No HA was detected in the presence of G. uralensis,
but it was detected when Z. officinale or C. cassia or both were
combined with A. carmichaelii; HA concentration was below
40% of the original concentration in A. carmichaelii. The effect
of combining singular components of G. uralensis, Z. officinale,
and C. cassia on HA concentration was also studied, which
showed that liquiritin and isoliquiritin were able to reduce the
concentration of HA. Other components did not affect HA
concentration. When isoliquiritin was mixed with A. carmi-
chaelii, the shape of the UV spectra changed. Formation of a
supramolecular structure was suggested, which was found to
possess a defined stoichiometry, binding constant, and mo-
lecular structure. Binding constants of HA with liquiritin in
different D2O/MeOD mixtures were determined for the first
time using 1H-NMR titration experiment.
A detailed study of the effect of decoction time on reducing
AC alkaloids toxicity was conducted using HPLC. A. carmi-
chaelii roots were processed according to the Chinese Phar-
macopeia [28]. First, the roots were washed with water and
soaked in edible mother liquor of mineral salts for several
days. Second, the mixture was boiled and rinsed with water.
Third, the roots were peeled, sliced, and soaked and rinsed in
water. After steaming and drying, P-ARs were obtained and
named as processed Fuzi or Baifupian (BFP). The P-ARs were
decocted over different time intervals (30 minutes, 60 mi-
nutes, or 120 minutes) forming three different decoctions
(DBFP-30, DBFP-60, and DBFP-120, respectively). Each decoc-
tion was analyzed using HPLC, and the obtained chromato-
grams were compared to those of the raw root and BFP. The
raw root was found to possess the highest concentrations of
AC, MA, and HA. In BFP, concentrations of these three alka-
loids were lower than those in raw Fuzi but higher than those
in DBFP. The results showed a stepwise decrease in the con-
centration of each alkaloid with increasing decoction time. In
DBFP-120, AC was undetectable and the concentrations of the
other two alkaloids reached the lowest values. Interestingly,
the content was almost similar to the total alkaloidal content
in the three prepared decoctions, suggesting that the toxic
alkaloids were successfully converted to nontoxic alkaloids.
The toxic effect of the prepared decoctionwas evaluated using
male and female Kunming mice. The median lethal dose
(LD50), maximal tolerance dose (MTD), minimal lethal dose
(MLD), and no-observed-adverse-effect level (NOAEL) were
determined for each decoction. The results indicated that
with an increase in the decoction time, acute toxicity of the
detoxified Fuzi decreased in the following order: DBFP-30 (LD50
145.1 g/kg, MTD 70 g/kg, MLD 100 g/kg, NOAEL 70 g/kg) >DBFP-
60 (very large LD50, MTD 160 g/kg, MLD 190 g/kg, NOAEL 100 g/
kg) > DBFP-120 (no LD50, unlimited MTD, unlimited MLD,NOAEL 130 g/kg). Additionally, adjuvant arthritis rats were
used to assess the pharmacological effect of detoxified Fuzi
roots. Adjuvant arthritis rats are special experimental models
that develop rheumatoid arthritis symptoms including
anorexia and bodyweight loss. Restoration of bodyweight can
only be achieved using detoxified Fuzi roots. The results
indicated no significant difference in the pharmacological ef-
fects of the three different decoctions. Based on these find-
ings, the authors recommended the use of DBFP-120
compared to other aconite forms because it exhibited the
same pharmacological effect without any acute toxicity.
An RRLCeMS/MS method was developed for analyzing the
components of an ancient TCM, Shen-Fu (Tables 1 and 2) [65].
The herbal formula is composed of Radix ginseng and Fuzi
(Radix Aconiti Lateralis Preparata) at a ratio of 3:2, and it is
prescribed for the treatment of diseases associated with the
signs of Yangqi decline and Yang exhaustion. The effect of the
mobile phase on the separation of alkaloids was evaluated,
and the results showed that the best peak shape and resolu-
tion were obtained using a mixture of acetonitrile and an
aqueous 0.05% formic acid solution. The LOD ranged from
0.01 ng/mL to 1.25 ng/mL, and the recovery percentage ranged
from 91.13% to 111.97% for all components including AC, MA,
and HA. The results indicated that AC was the least abundant
component among all the analytes.
A UPLCeESI/MS method was developed for the identifica-
tion of the constituents of complex herbal preparations used
in TCM including Sanhuang Xiexin Tang (SXT) and Fuzi Xiexin
Tang (FXT). SXT is composed of Rhei Radix et Rhizoma (Pol-
ygonaceae family, rhizomes of Rheum officinale), Scutellariae
Radix (Labiatae family, roots of Scutellaria baicalensis), and
Coptidis Rhizoma (Ranunculaceae family, rhizomes of Coptis
chinensis) (Tables 1 and 2) [43]. FXT possesses similar compo-
sition in addition to Aconiti Lateralis Radix Preparata
(Ranunculaceae family, roots of A. carmichaelii). SXT and FXT
are prepared either throughmaceration or through decoction.
The developed method was applied for the analysis of Aconiti
Lateralis Radix Preparata decoction, SXT, FXT,macerated SXT,
macerated FXT, SXT decoction, and FXT decoction. The re-
sults indicated a significant variation in the compositions of
the evaluated samples. Specifically, DDAs (AC, HA, and MA)
were not detected in FXT decoction and macerated FXT.
However, HAwas detected in Aconiti Lateralis Radix Preparata
decoction, but without AC and MA. In general, more constit-
uents were found in the decoction products compared to the
maceration products, which suggested more potent pharma-
cological activity of the decoction. The results also revealed
possible drugedrug interaction due to the complexity of the
herbal preparation and differences in their preparation
procedures.
A UHPLCeQ-TOF/MS method was developed to compare
the efficiency of detoxification mechanisms, as described in
Ayurveda and TCM, of the roots of Aconitum heterophyllum, A.
carmichaelii, and AKR [31]. In Ayurveda, the detoxification
mechanism or Shodhana is accomplished by treating the
herbal products with cow urine or cowmilk. In TCM, the most
general protocol for the detoxification of herbal products
containing Aconitum sp. is the use of water decoction. The
developed method was validated, and the LODs of AC, MA,
and HA were found to be 0.383 ng/mL, 0.438 ng/mL, and
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1.15 ng/mL, 1.31 ng/mL, and 0.264 ng/mL, respectively. Sam-
ples treated with cowmilk, cow urine, or water were analyzed
using the developed method. The results demonstrated that
the three detoxification mechanisms were effective in
reducing the concentrations of DDAs in all samples. However,
treating samples with cow urine was found to be less effective
than the other two protocols.
An efficient analytical method was developed for the
determination of aminoalcohol-diterpenoid alkaloids in the
lateral roots of A. carmichaelii (Fuzi) using solid-phase extrac-
tion followed by chromatographyetandem mass spectrom-
etry [66]. For the solid-phase extraction experiment, a good
recovery of aminoalcohol-terpenoid alkaloids was achieved
using 8% ammonia in methanol as the elution solvent. The
optimum mobile phase was found to be methanole0.1% for-
mic acid in the ratio of 80:20 (v/v). This mobile phase yielded a
good peak shape, acceptable separation, and a small tailing
factor. Specificity of the developed protocol was evaluated by
analyzing the blank solvent, mixed standard solution, refer-
ence solutions of the determined alkaloids, internal standard,
and sample solution. No interference was detected among the
solvent, alkaloids, or any other tested samples, suggesting the
specificity of the method. The developed method was suc-
cessfully applied for the determination of 13 aminoalcohol-
diterpenoid alkaloids in Fuzi samples obtained from
different sources and subjected to different processing
conditions.
A UFLC/MS-IT-TOF method was developed for the analysis
of alkaloidal constituents of Fuzi and FuzieGancaoherb pair
(FG), which consists of A. carmichaelii (Fuzi) and Roast Radix
Glycyrrhizae (Glycyrrhiza glabra, Gancao in Chinese) [47].
Diazepam was used as the internal standard in the developed
protocol. The optimum mobile phase for the separation of
alkaloids was found to be ammonium acetate and acetoni-
trile. Application of the developed protocol for the analysis of
Fuzi and FG resulted in the detection of 60 common peaks in
both samples. Among these peaks, those corresponding to 51
alkaloids were identified by accurate mass measurements
and fragmentation pathways. A semiquantitative analysis of
the samples, which was achieved through comparing the
obtained alkaloidal peak areas with the IS peak areas, pro-
vided a clearer picture on the differences of alkaloidal con-
tents between FG and Fuzi. It was found that the
concentrations of DDAs and aminoalcohol-diterpenoid alka-
loids were higher in FG decoction, while the concentrations
of MDAs were lower.
A quadrupole time-of-flight mass spectrometry
(UPLCeQ-TOFeMS) method was developed for the analysis
of a traditional herbal medicine, Wu-tou decoction, which is
used to treat rheumatic arthritis [67]. It is composed of
Aconiti Radix Cocta, Ephedrae Herba, Paeoniae Radix Alba,
Astragali Radix, and Glycyrrhiza Radix Preparata, indicating
the complexity of structures and difficulties in the deter-
mination of mixture components. The optimum mobile
phase for the developed method was found to be acetoni-
trileewater with 0.1% formic acid. Application of the
developed method led to the identification of 74 compo-
nents, including alkaloids, monoterpene glycosides,triterpene saponins, flavones, and flavone glycosides. The
components were confirmed by comparing the obtained
chromatogram with the chromatograms of individual herbs
and standard available components. Among the detected
compounds, 43 alkaloids, including Ephedra alkaloids as
well as aconite alkaloids, were detected in the positive ion
mode. Fragmentation pattern of the identified alkaloids was
studied and compared with that of the previous literature,
which aided in their identification. The developed method
can be added to the quality control tools that might be used
for the analysis of Wu-tou decoction.
A microcalorimetric method along with UPLC was devel-
oped for the analysis of Fuzi and three different P-AR products
including Yanfuzi, Heishunpian, and Paofupian [68]. A
microcalorimetric method can provide valuable information
on the growth andmetabolic status of cells under the effect of
the tested compounds. Under certain growth conditions,
cellular heat production and growth progress of cells produce
unique poweretime curves. From these curves, the effect of
certain compounds can be evaluated, suggesting the potential
action of these compounds. Using UPLC, the fingerprints of
Fuzi and its three P-AR products were developed and
compared. The effect of these samples on the metabolism of
rat mitochondria was investigated using the developed
microcalorimetricmethod. Finally, the results of the UPLC and
calorimetric method were correlated using a canonical cor-
relation analysis model. A study of the metabolism of mito-
chondrial rats suggested that the metabolic cycle can be
divided into four stages: Stage I, Stage II, Stage III, and Stage IV.
Certain thermokinetic parameters were also calculated,
including k, Q, Pmax, tmax, tlag, and Pav. Among these parame-
ters, the most important one was “k”, the exponential growth
rate of Stage II. It was found that metabolism reached its peak
when a sample concentration of 4.0 mg/mLwas used, and any
increase in the concentration led to a decrease inmetabolism.
The use of 4.0 mg/mL of the samples did not produce any
significant difference in the “k” values among Heisunpian and
Paofupianor Yanfuzi, which suggested lower efficiency
compared to the unprocessed Fuzi but higher safety. By
comparing the chromatograms of the analyzed samples, 26
common peaks were detected in the four samples. The effect
of these alkaloids on metabolism could be studied by the use
of the canonical correlation analysis model. It was found that
benzoylhypaconitine, MA, and HA had a positive effect on the
promotion of mitochondrial metabolism. On the other hand,
benzoylaconitine had a negative effect on metabolism.
An HPLCeQ-TOFeMS method was developed for the
analysis of Shen-Fu injection, which is a widely used Chinese
herbal formulation for cardiac diseases (Tables 1 and 2) [46]. It
is composed of red ginseng and P-ARs. The developedmethod
was highly sensitive and did not require sample pretreatment.
The LOQs ranged from 0.4 ng/mL to 18 ng/mL for DDAs. The
method was applied to nine batches of Shen-Fu injection, and
it showed high batch-to-batch reproducibility. Application of
the developed method led to the identification of 44 com-
pounds and quantification of 24 major alkaloids and
ginsenosides.
A functionalized analytical method was developed for the
analysis of Fuzilizhong pills. These pills are amodified form of
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Diseases. It consists of Panax ginseng (Ren Shen), A. carmichaelii
Debx. (Fu Zi, Zhi), G. uralensis, Glycyrrhiza inflata or G. glabra
(Gan Cao), Atractylodes macrocephala (Bai Zhu), and Z. officinale
(Gan Jiang) [45]. This medication is prescribed for dyspnea and
pulmonary edema. For the analysis of Fuzilizhong pills, a
UPLCeMS method and a luciferase reporter assay system to
simultaneously screen nuclear factor kappa beta (NF-kB) in-
hibitors and Beta-2 Adrenergic Receptor (b2AR) agonists were
applied. Inhibition of NF-kB is related to lower inflammatory
reaction. Stimulation of b2AR is related to the activation of
adenylyl cyclase, cyclic adenosine monophosphate (cAMP),
and protein kinase A, and phosphorylation of numerous
effector proteins, which lead to the relaxation of tracheal
smooth muscles. The use of 250 mg/mL or 1000 mg/mL of
Fuzilizhong pills led to the inhibition of tumor necrosis factor
alpha-induced NF-kB production and activation of b2AR
signal. The results indicated that MA, flaconitine, BMA, AC,
and HA are potent NF-kB inhibitors.4. Conclusion
Aconitum and its products have played an important role in
human history. It was one of the most feared plants in all
ancient civilizations. Despite its extreme toxicity, it was
sought for its healing and mysterious power. Indian and
Chinese civilizations studied this plant extensively and
introduced detailed treatises on how to prepare nontoxic
decoctions and extracts from this plant. More than 70
different preparation methods were reported in ancient
scriptures, and most of these methods are still used today.
The Chinese Pharmacopeia established certain criteria for
the total contents of toxic alkaloids, which should be refer-
enced by any producer preparing herbal products containing
Aconitum. Despite these measurements, a wide variation in
concentrations of toxic alkaloids has been recorded in the
marketed preparations, exposing the public to unnecessary
risks. The recent advances in analytical techniques, espe-
cially HLPC, MS, and CE, allowed the accurate determination
of each alkaloid in herbal mixtures, thus establishing more
precise limits for the toxic alkaloids in aconite preparations
intended for human consumption. Theses analytical tech-
niques are available in quality control laboratories and can
easily be applied for assessing the quality of aconite prod-
ucts. Based on the summary presented in this review, it is
highly recommended to change the original measures set in
pharmacopeias that focused only on the determination of AC
and replace the tests with advanced analytical methods
establishing the accurate concentrations of every aconite
alkaloids.Conflicts of interest
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